Narrative Research in Applied Linguistics, Language Education, and TESOL Quarterly
TESOL Quarterly · 2026-06 · 60 (2) · 752-766
DOI: 10.1002/tesq.70145 ↗Kurz gefasst
Fachartikel in der Zeitschrift TESOL Quarterly, online erschienen am 05.05.2026. Verfasst von Alice Chik. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This paper aims to position narrative research within the realm of language education and examine its methodological application in TESOL Quarterly publications. I will first discuss the earlier developments stemming from life history research before focusing on the key conceptual principles explored in prior studies within language education. Two publications from TESOL Quarterly—by Tsui (2007) and Séguis et al. (2024)—will illustrate the methodological advancements over two decades, transitioning from a single qualitative case study (Tsui, 2007) to a mixed‐methods design (Séguis et al., 2024). These two works also emphasize the growing need for rigorous research that strengthens ethical considerations and representation, and enhances methodological designs to effectively accommodate the collection and analysis of multimodal data. The paper concludes with a call for more narrative research that embraces a longitudinal and inclusive approach to data collection, as well as greater transparency in analytical methods and reporting.
Zitieren
APA
Chik, A. (2026). Narrative Research in Applied Linguistics, Language Education, and TESOL Quarterly. TESOL Quarterly, 60(2), 752-766. https://doi.org/10.1002/tesq.70145
Vancouver
Chik A. Narrative Research in Applied Linguistics, Language Education, and TESOL Quarterly. TESOL Quarterly. 2026;60(2):752-766. doi:10.1002/tesq.70145
BibTeX
@article{Chik2026,
author = {Chik, Alice},
title = {Narrative Research in Applied Linguistics, Language Education, and TESOL Quarterly},
journal = {TESOL Quarterly},
year = {2026},
volume = {60},
number = {2},
pages = {752--766},
doi = {10.1002/tesq.70145}
}
EUVIMED